OVOTRANSFERRINS FOR USE IN THE TREATMENT OF IRON DEFICIENCY ANAEMIA
Ovotransferrins with a degree of iron saturation from 0 to 15% are useful in the treatment of iron deficiency and iron deficiency anaemia, increasing the cell viability on gastric and intestinal cell models with respect to the holo-OvT 100%, when tested at the same concentrations, showing also a sur...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | GRISENTI, Paride FERRARI, Valerio Maria BAGGIO, Maria Carla |
| description | Ovotransferrins with a degree of iron saturation from 0 to 15% are useful in the treatment of iron deficiency and iron deficiency anaemia, increasing the cell viability on gastric and intestinal cell models with respect to the holo-OvT 100%, when tested at the same concentrations, showing also a surprisingly better time dependent absorption of iron ions and a physiological trend allowing a single oral administration in 24 hours.
L'invention concerne des ovotransferrines ayant un degré de saturation en fer de 0 à 15 %, utiles dans le traitement de l'anémie ferriprive et de la carence en fer, qui augmentent la viabilité cellulaire sur des modèles de cellules gastriques et intestinales par rapport à l'holo-OvT 100 %, lorsqu'elles sont testées aux mêmes concentrations, et qui montrent également une absorption des ions ferriques en fonction du temps considérablement meilleure et une tendance physiologique permettant une administration orale unique en 24 heures. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2022175509A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2022175509A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2022175509A13</originalsourceid><addsrcrecordid>eNqNyrEKwkAMANAuDqL-Q8BZaE-KOIYzRzM0gVxUnEqRcxIt1P_HxQ9westbVlEv6oaSE5mxZEhqcM4ELOAdgRuh9yQOmoBNBU6UODJJvAEKUs-4rhaP8TmXzc9VtU3ksduV6T2UeRrv5VU-w1VDHUJzaNv6iM3-v_UF4FAsXQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>OVOTRANSFERRINS FOR USE IN THE TREATMENT OF IRON DEFICIENCY ANAEMIA</title><source>esp@cenet</source><creator>GRISENTI, Paride ; FERRARI, Valerio Maria ; BAGGIO, Maria Carla</creator><creatorcontrib>GRISENTI, Paride ; FERRARI, Valerio Maria ; BAGGIO, Maria Carla</creatorcontrib><description>Ovotransferrins with a degree of iron saturation from 0 to 15% are useful in the treatment of iron deficiency and iron deficiency anaemia, increasing the cell viability on gastric and intestinal cell models with respect to the holo-OvT 100%, when tested at the same concentrations, showing also a surprisingly better time dependent absorption of iron ions and a physiological trend allowing a single oral administration in 24 hours.
L'invention concerne des ovotransferrines ayant un degré de saturation en fer de 0 à 15 %, utiles dans le traitement de l'anémie ferriprive et de la carence en fer, qui augmentent la viabilité cellulaire sur des modèles de cellules gastriques et intestinales par rapport à l'holo-OvT 100 %, lorsqu'elles sont testées aux mêmes concentrations, et qui montrent également une absorption des ions ferriques en fonction du temps considérablement meilleure et une tendance physiologique permettant une administration orale unique en 24 heures.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220825&DB=EPODOC&CC=WO&NR=2022175509A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220825&DB=EPODOC&CC=WO&NR=2022175509A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GRISENTI, Paride</creatorcontrib><creatorcontrib>FERRARI, Valerio Maria</creatorcontrib><creatorcontrib>BAGGIO, Maria Carla</creatorcontrib><title>OVOTRANSFERRINS FOR USE IN THE TREATMENT OF IRON DEFICIENCY ANAEMIA</title><description>Ovotransferrins with a degree of iron saturation from 0 to 15% are useful in the treatment of iron deficiency and iron deficiency anaemia, increasing the cell viability on gastric and intestinal cell models with respect to the holo-OvT 100%, when tested at the same concentrations, showing also a surprisingly better time dependent absorption of iron ions and a physiological trend allowing a single oral administration in 24 hours.
L'invention concerne des ovotransferrines ayant un degré de saturation en fer de 0 à 15 %, utiles dans le traitement de l'anémie ferriprive et de la carence en fer, qui augmentent la viabilité cellulaire sur des modèles de cellules gastriques et intestinales par rapport à l'holo-OvT 100 %, lorsqu'elles sont testées aux mêmes concentrations, et qui montrent également une absorption des ions ferriques en fonction du temps considérablement meilleure et une tendance physiologique permettant une administration orale unique en 24 heures.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwkAMANAuDqL-Q8BZaE-KOIYzRzM0gVxUnEqRcxIt1P_HxQ9westbVlEv6oaSE5mxZEhqcM4ELOAdgRuh9yQOmoBNBU6UODJJvAEKUs-4rhaP8TmXzc9VtU3ksduV6T2UeRrv5VU-w1VDHUJzaNv6iM3-v_UF4FAsXQ</recordid><startdate>20220825</startdate><enddate>20220825</enddate><creator>GRISENTI, Paride</creator><creator>FERRARI, Valerio Maria</creator><creator>BAGGIO, Maria Carla</creator><scope>EVB</scope></search><sort><creationdate>20220825</creationdate><title>OVOTRANSFERRINS FOR USE IN THE TREATMENT OF IRON DEFICIENCY ANAEMIA</title><author>GRISENTI, Paride ; FERRARI, Valerio Maria ; BAGGIO, Maria Carla</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2022175509A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>GRISENTI, Paride</creatorcontrib><creatorcontrib>FERRARI, Valerio Maria</creatorcontrib><creatorcontrib>BAGGIO, Maria Carla</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GRISENTI, Paride</au><au>FERRARI, Valerio Maria</au><au>BAGGIO, Maria Carla</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>OVOTRANSFERRINS FOR USE IN THE TREATMENT OF IRON DEFICIENCY ANAEMIA</title><date>2022-08-25</date><risdate>2022</risdate><abstract>Ovotransferrins with a degree of iron saturation from 0 to 15% are useful in the treatment of iron deficiency and iron deficiency anaemia, increasing the cell viability on gastric and intestinal cell models with respect to the holo-OvT 100%, when tested at the same concentrations, showing also a surprisingly better time dependent absorption of iron ions and a physiological trend allowing a single oral administration in 24 hours.
L'invention concerne des ovotransferrines ayant un degré de saturation en fer de 0 à 15 %, utiles dans le traitement de l'anémie ferriprive et de la carence en fer, qui augmentent la viabilité cellulaire sur des modèles de cellules gastriques et intestinales par rapport à l'holo-OvT 100 %, lorsqu'elles sont testées aux mêmes concentrations, et qui montrent également une absorption des ions ferriques en fonction du temps considérablement meilleure et une tendance physiologique permettant une administration orale unique en 24 heures.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2022175509A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | OVOTRANSFERRINS FOR USE IN THE TREATMENT OF IRON DEFICIENCY ANAEMIA |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T06%3A50%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GRISENTI,%20Paride&rft.date=2022-08-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2022175509A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |